Insulin aspart, recombinant Subcutaneous and Ocufen eent
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ocufen eent and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: flurbiprofen ophthalmic
Brand name: Ocufen
Synonyms: Ocufen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Ocupress
- Insulin aspart, recombinant Subcutaneous-Ocusert Pilo
- Insulin aspart, recombinant Subcutaneous-Ocuvel
- Insulin aspart, recombinant Subcutaneous-Ocuvite
- Insulin aspart, recombinant Subcutaneous-Ocuvite Adult 50+
- Insulin aspart, recombinant Subcutaneous-Ocuvite Extra
- Ocufen eent-Insulin degludec
- Ocufen eent-Insulin Degludec (U-100) Prefilled Pens
- Ocufen eent-Insulin Degludec (U-100) Vials
- Ocufen eent-Insulin Degludec (U-200) Prefilled Pens
- Ocufen eent-Insulin degludec and liraglutide
- Ocufen eent-Insulin degludec and liraglutide Subcutaneous